Prevalance of Cesarean Section Niche in Patients With Abnormal Uterine Bleeding

NCT ID: NCT05067296

Last Updated: 2021-10-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-10-01

Study Completion Date

2022-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prevalance of Cesarean section niche in patients with abnormal uterine bleeding

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cesarean Section Niche and Abnormal Uterine Bleeding

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cesarean section niche and patients with abnormal uterine bleeding

Observation by Tvs

By TVS

Intervention Type OTHER

Uses of TVS to diagnosis of Cesarean section niche in patients with abnormal uterine bleeding

Abnormal uterine bleeding in patients without Cesarean section niche

Observation by Tvs

By TVS

Intervention Type OTHER

Uses of TVS to diagnosis of Cesarean section niche in patients with abnormal uterine bleeding

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

By TVS

Uses of TVS to diagnosis of Cesarean section niche in patients with abnormal uterine bleeding

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Age between 20-40 years old. Non pregnant women. Previous cesarean section (one or more). Presence of abnormal uterine bleeding

Exclusion Criteria

Virgins Pregnant women. Patients with vaginal delivery. Patients with uterine bleeding with known cause.
Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mahmoud Ramadan Hafez

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mahmoud Ramadan Hafez

Mahmoud Ramadan Hafez Ahmed

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sohag University

Sohag, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mahmoud R Hafez, Resident

Role: CONTACT

01095070933

Sabry M Mohamed, Professor Dr

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Osama R Elsherief

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soh-Med-21-09-06

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Determination of Blood Loss After CS
NCT04549012 UNKNOWN EARLY_PHASE1